Financials
Value Q1, 25Q2, 25 TTM Selling/general/admin expenses —— — Research & development —— — Operating income 445 M676 M 1.68 B Non-Operating Income, Total 30 M33 M 120 M Interest expense, net of interest capitalized 22 M24 M 93 M Non-Operating Income, excl. Interest Expenses 8 M9 M 27 M Unusual income/expense —— — Pretax income 450 M680 M 1.7 B Equity in earnings —— — Taxes 111 M179 M 456 M Non-controlling/minority interest —— — After tax other income/expense -2 M5 M 6 M Net income before discontinued operations 339 M501 M 1.25 B Discontinued operations —— — Net income 339 M501 M 1.25 B Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 339 M501 M 1.25 B Basic earnings per share (Basic EPS) 0.921.41 3.43 Diluted earnings per share (Diluted EPS) 0.91.38 3.33 Average basic shares outstanding 367 M355 M — Diluted shares outstanding 378 M362 M — EBITDA —— — EBIT 445 M676 M 1.68 B Cost of revenue 2.08 B1.72 B 8.7 B Other cost of goods sold —— — Depreciation & amortization (cash flow) —— —